Opioid-induced hypogonadism: Pathophysiology, clinical and therapeutics review (Abstract)

Opioid-induced hypogonadism: Pathophysiology, clinical and therapeutics review Clin Exp Pharmacol Physiol May 2020 https://pubmed.ncbi.nlm.nih.gov/31886562/ Opioids are pivotal therapeutics in the management of escalated chronic pain (moderate-severe). In the last two decades, the increased prescription rate and the prolonged usage of opioids shed light on opioid-induced endocrinopathy. Opioid-induced hypogonadism (OHG) results upon long-term opioid therapy. Clinically, […]

Dr Elissa Mullen – 25th July 2018 Radio Show (LDN, low dose naltrexone)

Dr Elissa Mullen – 25th July 2018 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo. Dr Elissa Mullen shares her Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood. Dr Elissa Mullen practices general adult medicine and specialises in chronic disease weight loss, bio-identical hormones and natural solutions to […]